8-22165439-G-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NM_006129.5(BMP1):c.34G>C(p.Gly12Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000639 in 1,564,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000057 ( 0 hom. )
Consequence
BMP1
NM_006129.5 missense
NM_006129.5 missense
Scores
3
1
15
Clinical Significance
Conservation
PhyloP100: -0.491
Genes affected
BMP1 (HGNC:1067): (bone morphogenetic protein 1) This gene encodes a protein that is capable of inducing formation of cartilage in vivo. Although other bone morphogenetic proteins are members of the TGF-beta superfamily, this gene encodes a protein that is not closely related to other known growth factors. This gene is expressed as alternatively spliced variants that share an N-terminal protease domain but differ in their C-terminal region. [provided by RefSeq, Aug 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-22165439-G-C is Pathogenic according to our data. Variant chr8-22165439-G-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 37307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.13490069). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BMP1 | NM_006129.5 | c.34G>C | p.Gly12Arg | missense_variant | 1/20 | ENST00000306385.10 | NP_006120.1 | |
BMP1 | NM_001199.4 | c.34G>C | p.Gly12Arg | missense_variant | 1/16 | ENST00000306349.13 | NP_001190.1 | |
BMP1 | NR_033403.2 | n.68G>C | non_coding_transcript_exon_variant | 1/20 | ||||
BMP1 | NR_033404.2 | n.68G>C | non_coding_transcript_exon_variant | 1/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BMP1 | ENST00000306385.10 | c.34G>C | p.Gly12Arg | missense_variant | 1/20 | 1 | NM_006129.5 | ENSP00000305714 | P1 | |
BMP1 | ENST00000306349.13 | c.34G>C | p.Gly12Arg | missense_variant | 1/16 | 1 | NM_001199.4 | ENSP00000306121 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152132Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
2
AN:
152132
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000108 AC: 2AN: 185424Hom.: 0 AF XY: 0.00000952 AC XY: 1AN XY: 105010
GnomAD3 exomes
AF:
AC:
2
AN:
185424
Hom.:
AF XY:
AC XY:
1
AN XY:
105010
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000566 AC: 8AN: 1412540Hom.: 0 Cov.: 32 AF XY: 0.00000712 AC XY: 5AN XY: 702430
GnomAD4 exome
AF:
AC:
8
AN:
1412540
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
702430
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74430
GnomAD4 genome
AF:
AC:
2
AN:
152240
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:1Other:1
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 17, 2023 | Experimental studies have shown that this missense change affects BMP1 function (PMID: 22482805). For these reasons, this variant has been classified as Pathogenic. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 37307). This missense change has been observed in individuals with osteogenesis imperfecta (PMID: 22482805, 24091809, 29499418). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs318240762, gnomAD 0.002%). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 12 of the BMP1 protein (p.Gly12Arg). - |
Osteogenesis imperfecta Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 14, 2024 | Variant summary: BMP1 c.34G>C (p.Gly12Arg) results in a non-conservative amino acid change in the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.1e-05 in 185424 control chromosomes. c.34G>C has been reported in the literature in individuals affected with Osteogenesis Imperfecta (example, Syx_2015,Valencia_2013). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal transcripts in fibroblasts from a patient carrying homozygous p.Gly12Arg (Valencia_2013). The following publications have been ascertained in the context of this evaluation (PMID: 25656619, 24648371). ClinVar contains an entry for this variant (Variation ID: 37307). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Osteogenesis imperfecta type 13 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2014 | - - |
Abnormality of the skeletal system Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Kariminejad - Najmabadi Pathology & Genetics Center | Jul 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.;L
MutationTaster
Benign
N;N;N;N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Benign
T;T;D;T
Sift4G
Benign
T;T;D;T
Polyphen
B;.;.;B
Vest4
MutPred
Gain of helix (P = 0.0128);Gain of helix (P = 0.0128);Gain of helix (P = 0.0128);Gain of helix (P = 0.0128);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at